Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology

Post-infarct remodelling: contribution of wound healing and inflammation

(2008) S. Frantz et al.   CARDIOVASCULAR RESEARCH

Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial Infarction

(2008) Monica Salio et al.   CIRCULATION

Predictors of Outcome in Patients With Suspected Myocarditis

(2008) Ingrid Kindermann et al.   CIRCULATION

Prevention of Heart Failure

(2008) Douglas D. Schocken et al.   CIRCULATION

Aging and Remodeling During Healing of the Wounded Heart: Current Therapies and Novel Drug Targets

(2008) Bodh Jugdutt   CURRENT DRUG TARGETS

Acute viral myocarditis

(2008) R. Dennert et al.   EUROPEAN HEART JOURNAL

Periostin is essential for cardiac healingafter acute myocardial infarction

(2008) Masashi Shimazaki et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions

(2008) AS Savchenko et al.   JOURNAL OF PATHOLOGY

Impact of Oxypurinol in Patients With Symptomatic Heart Failure

(2008) Joshua M. Hare et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial

(2008) Guillermo Torre-Amione et al.   LANCET

Upregulation of Pentraxin-3 in Human Endothelial Cells After Lysophosphatidic Acid Exposure

(2007) Cindy Gustin et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY